SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival

Wudhikarn, K; Loghavi, S; Mangaonkar, AA; Al-Kali, A; Binder, M; Carr, R; Reichard, K; Finke, C; Howard, M; Gangat, N; Tefferi, A; Komrokji, R; Ali, N; Lasho, T; Ketterling, R; Padron, E; Patnaik, MM

Patnaik, MM (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55901 USA.

BLOOD ADVANCES, 2020; 4 (22): 5716